Department of Health and Human Services

Part 1. Overview Information

Participating Organization(s)

National Institutes of Health (NIH)

Components of Participating Organizations

National Institute of Dental and Craniofacial Research (NIDCR)

Office of AIDS Research (OAR)

All applications to this funding opportunity announcement should fall within the mission of the Institutes/Centers. The following NIH Offices may co-fund applications assigned to those Institutes/Centers.

Division of Program Coordination, Planning and Strategic Initiatives, Office of Disease Prevention (ODP)

Office of Behavioral and Social Sciences Research (OBSSR)

Office of Research on Women's Health (ORWH)

Funding Opportunity Title
Community Engagement Evaluation and Data Coordination (CEED) Hub to Advance Data and Practice Transformation for Optimizing Oral Health for All (U01, Clinical Trial Not Allowed)
Activity Code

U01 Research Project – Cooperative Agreements

Announcement Type
New
Related Notices
Funding Opportunity Number (FON)
RFA-DE-27-001
Companion Funding Opportunity
PAR-27-015 , UG3/ UH3 Phase 1 Exploratory/Developmental Cooperative Agreement/Exploratory/Developmental Cooperative Agreement Phase II
Number of Applications

See Part 2, Section III. 3. Additional Information on Eligibility.

Assistance Listing Number(s)
93.121, 93.310, 93.313
Funding Opportunity Purpose

The purpose of this Notice of Funding Opportunity (NOFO) is to seek applications for a Community Engagement Evaluation and Data coordination hub (CEED) for the Community-Based Participatory Research (CBPR) consortium: Advancing Data and Practice Transformation (ADAPT) for Optimizing Oral Health for All. In addition to CEED, the ADAPT consortium will include separately funded CBPR projects, which will receive consultative services from the NIH Community Engagement Alliance Consultative Resource (CEACR) and join in the Science Collaborative for Health and Artificial Intelligence Reduction of Errors (SCHARE) platform for the overarching goal of promoting data use and transformational community engagement to optimize oral health for all people. The CEED hub will coordinate communications and various activities in support of CBPR projects and consortium functions in three domains:1) Data Planning, Consultation, and Technical Assistance for Research Methodology and Analytics; 2) Community Engagement Evaluation; and 3) ADAPT Infrastructure and Operational Support.

Funding Opportunity Goal(s)

The mission of the National Institute of Dental and Craniofacial Research (NIDCR) is to advance fundamental knowledge about dental, oral, and craniofacial (DOC) health and disease and translate these findings into prevention, early detection, and treatment strategies that improve overall health for all individuals and communities across the lifespan.

Key Dates

Posted Date
April 27, 2026
Open Date (Earliest Submission Date)
September 19, 2026
Application Due Dates Review and Award Cycles
New Renewal / Resubmission / Revision (as allowed) AIDS - New/Renewal/Resubmission/Revision, as allowed Scientific Merit Review Advisory Council Review Earliest Start Date
October 19, 2026 Not Applicable Not Applicable March 2027 May 2027 July 2027

All applications are due by 5:00 PM local time of applicant organization. 

Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.

Due Dates for E.O. 12372

Not Applicable

Expiration Date
October 20, 2026
Required Application Instructions

It is critical that applicants follow the instructions in the Research (R) Instructions in the How to Apply - Application Guide, except where instructed to do otherwise (in this NOFO or in a Notice from NIH Guide for Grants and Contracts).

Conformance to all requirements (both in the Application Guide and the NOFO) is required and strictly enforced. Applicants must read and follow all application instructions in the Application Guide as well as any program-specific instructions noted in Section IV. When the program-specific instructions deviate from those in the Application Guide, follow the program-specific instructions.

Applications that do not comply with these instructions may be delayed or not accepted for review.

There are several options available to submit your application through Grants.gov to NIH and Department of Health and Human Services partners. You must use one of these submission options to access the application forms for this opportunity.

  1. Use the NIH ASSIST system to prepare, submit and track your application online.
  2. Use an institutional system-to-system (S2S) solution to prepare and submit your application to Grants.gov and eRA Commons to track your application. Check with your institutional officials regarding availability.
  3. Use Grants.gov Workspace to prepare and submit your application and eRA Commons to track your application.

Part 2. Full Text of Announcement

Section I. Notice of Funding Opportunity Description

This Notice of Funding Opportunity (NOFO) seeks applications for a Community Engagement Evaluation and Data coordination hub (CEED) for the Community-Based Participatory Research (CBPR) consortium:  Advancing Data and Practice Transformation (ADAPT) for Optimizing Oral Health for All. In addition to CEED, the ADAPT consortium will include separately funded CBPR projects, which will receive consultative services from the NIH Community Engagement Alliance Consultative Resource (CEACR) and join in the Science Collaborative for Health and Artificial Intelligence Reduction of Errors (SCHARE) platform for the overarching goal of promoting data use and transformational community engagement to optimize oral health for all people across the lifespan. CEED will coordinate communications and various activities for the consortium in three domains: 1) Data Planning, Consultation, and Technical Assistance for Research Methodology and Analytics; 2) Community Engagement Evaluation; and 3) ADAPT Consortium Infrastructure and Operational Support.

Key Definitions for this NOFO:

Community: A social group of any size whose members reside in a specific locality, share government, and often have a common cultural and historical heritage. Community may be self-defined or defined by the catchment areas of local government or service providers (e.g. residents served by a county school district or community clinic). Examples of communities include but not limited to neighborhoods, towns, cities, counties, school districts, reservations or Tribal communities, military bases, and college campuses. Virtual or other communities that do not reside in the same geographic location are not the focus of this initiative.

Community-Based Participatory Research (CBPR): A highly-evolved collaborative approach in research that expects researchers and groups of people affiliated by, for example, geographic proximity or other defining characteristics to identify and address issues affecting the well-being of those people as equivalent partners in all aspects of the research process. Community engagement in research can be viewed in the context of a continuum, ranging from consultation with community partners to community-driven research. Moving along the continuum, as the relationships between community partners and researchers grow, the meaningfulness to community partners and the impact of research to community health increase.

Cross-Sector Partnerships: A collaborative partnership between two or more community-based service sectors with the goal of leveraging the resources and expertise of the partners to achieve a mutually beneficial outcome. In ADAPT, cross-sector partnerships must include healthcare-related (e.g. businesses that provide dental and medical services, equipment/supplies, insurance) and non-healthcare-related organizations and individuals from these service sectors. 

Levels of Influence: The socio-ecological levels, such as individual, interpersonal, organizational, community, or societal levels, at which specific domains of factors (e.g. biological, behavioral, physical/built environment, sociocultural environment, healthcare system) operate to influence risks and resilience for subsequent health outcomes. In ADAPT, the intervention(s) of interest must directly address factors at the community and/or societal levels of influence, not merely be implemented at these levels. 

Background: Despite considerable advances in science and the practice of preventing and controlling oral diseases over the last 20 years, oral diseases such as dental caries and periodontal disease remain among the most common chronic diseases across the lifespan. In the United States, approximately one in four preschool children reportedly have experienced caries in their primary teeth, and nine in ten adults ages 20-64 years have either treated or untreated caries in their permanent teeth. Periodontal disease is more common as people age, and more than 40% of US adults 30 years or older have some form of periodontitis. Chronic oral diseases such as dental caries and periodontal diseases progress silently over the lifespan, influenced by various individual and contextual factors, resulting in pain and loss of teeth, supporting tissues, and basic functions of the mouth such as eating and speaking thus impairing a person’s health and psychosocial and economic well-being. Among US adults 65 years and older, approximately 25% have lost eight or fewer teeth, and the prevalence of complete tooth loss is more than 15%. Poor oral health and untreated oral diseases are particularly common among populations with low socioeconomic status. 

The mouth is a portal to chronic disease risk, with tobacco use and an unhealthy diet also contributing to poor oral health outcomes and America's chronic disease crisis. The mouth, which is home to over 700 microbial species, often shows early signs of physiological challenges such as altered immunity and inflammation while untreated oral diseases and sustained localized inflammation in the mouth can trigger the initiation of systemic inflammatory responses and multimorbidity.

The conditions in which people are born, grow, learn, work, play, live, and age, and the wider set of upstream factors shaping the conditions of daily life (e.g. systems and policies that impact social, economic, educational, and neighborhood conditions as well as health care access and quality) can improve, maintain, or hinder health through multiple direct, indirect, and interacting mechanistic pathways. They may also interact with downstream factors to influence disease risks and resilience to further promote or compromise health across the life-course. Enhanced access to high-quality, affordable, and  evidence-based oral health services is an important step towards improving oral health in communities. Nevertheless, multi-level common risk factors giving rise to oral and systemic multimorbidity must be considered to increase the efficiency and value of oral health care delivery for optimizing oral and overall health for all people. 

CBPR utilizes a collaborative approach that engages community members as equivalent partners with scientists throughout the research process. The NIH has supported research using CBPR strategies for several decades to accelerate the translation of scientific discovery into communities. Despite progress, gaps remain in the level of community engagement within NIH-funded research, presenting opportunities to deepen community-researcher partnerships and enhance the impact of research in improving community health. 

The ADAPT Consortium Structure: The ADAPT consortium comprises the Community Engagement Evaluation and Data Coordination hub (CEED) awarded through this NOFO and separately funded UG3/UH3 research projects. The consortium will receive consultative services from the NIH Community Engagement Alliance Consultative Resource (CEACR) and join in the Science Collaborative for Health and Artificial Intelligence Reduction of Errors (SCHARE) platform. CEACR, which was established within NIH Community Engagement Alliance (CEAL), provides curated expert consultations tailored to the needs of each consultee by using a panel of community and academic experts in community engagement. In this initiative, CEACR will be available to provide up to three episodic, expert panel consultations for each project, as proposed and budgeted in the application. CEACR will also provide longitudinal consultative services (e.g. targeted consultations, office hours and webinars etc.) that are aligned with CEACR objectives and scope of work supported by NIDCR-co-funding to promote adherence to the principles of community-partnered research approaches and enhancing participant representation in CBPR projects. SCHARE, a cloud-based platform developed by a collaboration of several NIH Institutes, includes datasets relevant to population health science to enable researchers to link, analyze, and export data within a secure and collaborative workspace that is equipped with advanced computational tools. In this consortium, CEED will manage the ADAPT workspace provided by SCHARE, and each CBPR project will have its own SCHARE workspace. CEED will coordinate communications and various activities in support of CBPR projects and consortium functions in three domains: 1) Data Planning, Consultation, and Technical Assistance for Research Methodology and Analytics; 2) Community Engagement Evaluation; and 3) ADAPT Consortium Infrastructure and Operational Support. CEED will chair the ADAPT Steering Committee (SC) which will serve as the primary governing body of the consortium and will include at least two representatives from each research project (e.g. one from research institutions and the other from partner community organizations) and non-voting members such as NIDCR Program staff and representatives from SCHARE and CEACR. The ADAPT SC will meet quarterly and engage in a range of planning and evaluation activities for the consortium including data harmonization, assessing needs and priorities for community engagement capacity building, and reviewing and planning of manuscripts or other resources/products. In addition to the SC, an external expert committee may be convened by NIDCR. Applicants are encouraged to review the companion CBPR research project UG3/UH3 NOFO (PAR-27-015) to fully understand the consortium objectives and activities.

Scope of Work for the CEED hub:

CEED’s scope of work will be in the three domains, and activities may include but are not limited to:

1. Data Planning, Consultation, and Technical Assistance on Research Methodology and Analytics

  • Facilitate data harmonization and develop agreements, as appropriate, in collaboration with CBPR projects, to enable data sharing and aggregation for consortium-wide research data.
  • Provide consultation services and technical assistance on measurements and standardized data collection for individual- and population-level measures of oral health, common risk factors, contextual factors, including but not limited to those included in the PhenX Toolkit.
  • Assist CBPR projects with the compilation of publicly available surveillance, administrative, or other relevant local, state, or federal data. 
  • Provide methodologic and analytic guidance and consultation for CBPR projects. CEED is expected to have expertise in design and analytic methods appropriate for studies that evaluate intervention effects beyond the individual level.

2. Community Engagement Evaluation 

  • Employ an appropriate planning and evaluation framework/model and metrics to monitor the core principles of community engagement/partnerships and support the continuous improvement of community engagement efforts in CBPR projects. Conduct evaluation research by collecting qualitative and quantitative data periodically from CBPR project teams and their partners.
  • Monitor and coordinate the ADAPT SC's review/feedback on the community engagement evaluation data and organize capacity building activities such as CEACR office hours and webinars (up to two activities per year) guided by the SC recommendations to optimize community-researcher partnerships and outreach efforts for recruitment and retention in CBPR projects. 

3. ADAPT Consortium Infrastructure and Operational Support

  • Organize, in coordination with NIDCR staff, the ADAPT SC including at least two representatives from each CBPR Project (e.g. one from research institutions and another from partner community organizations) and non-voting members such as NIDCR Program staff and representatives of SCHARE and CEACR, and coordinate communication, planning, implementation, and evaluation of consortium activities. Consortium activities may include but are not limited to data harmonization, assessment of needs and priorities for community engagement capacity building, an annual meeting, reviewing and planning of manuscripts or other resource/products authorship, and data sharing.
  • Identify, curate, and recommend oral health datasets with zip-code data in the public domain to be hosted by SCHARE data ecosystem.
  • Manage the collaborative workspace assigned to ADAPT in SCHARE and provide technical assistance to CBPR projects’ data coordinators on the Terra resources and analytics. Expertise is expected in data management/engineering and fluency in Python and R coding languages.

Applications Not Responsive to the NOFO

  • Applications that do not propose activities in all three (3) required domains (Data Planning, Consultation, and Technical Assistance on Research Methodology and Analytics; Community Engagement Evaluation; and ADAPT Consortium Infrastructure and Operational Support).
  • Applications that include a clinical trial.

Non-responsive applications will not be reviewed. Applicants are strongly encouraged to reach out to this NOFO's Scientific Contact to discuss whether their planned applications are responsive.

See Section VIII. Other Information for award authorities and regulations.

Section II. Award Information

Funding Instrument

Cooperative Agreement: A financial assistance mechanism used when there will be substantial Federal scientific or programmatic involvement. Substantial involvement means that, after award, NIH scientific or program staff will assist, guide, coordinate, or participate in project activities. See Section VI.2 for additional information about the substantial involvement for this NOFO.

Application Types Allowed
New

The OER Glossary and the How to Apply Application Guide provide details on these application types. Only those application types listed here are allowed for this NOFO.

Clinical Trial?

Not Allowed: This NOFO only accepts applications that do not propose clinical trials. Note: Applications may propose activities involving human subjects that are not deemed clinical trials.

Funds Available and Anticipated Number of Awards

NIDCR intends to commit $1M in FY2027 to fund one (1) award. 

Award Budget

Application budgets are not limited but need to reflect the actual needs of the proposed project.

Award Project Period

The maximum project period is 5 years.

NIH grants policies as described in the NIH Grants Policy Statement will apply to the applications submitted and awards made from this NOFO.

Section III. Eligibility Information

1. Eligible Applicants

Eligible Organizations

Higher Education Institutions - Includes all types

  • Public/State Controlled Institutions of Higher Education
  • Private Institutions of Higher Education

Nonprofits Other Than Institutions of Higher Education

  • Nonprofits with 501(c)(3) IRS Status (Other than Institutions of Higher Education)
  • Nonprofits without 501(c)(3) IRS Status (Other than Institutions of Higher Education)

For-Profit Organizations

  • Small Businesses
  • For-Profit Organizations (Other than Small Businesses)

Local Governments

  • State Governments
  • County Governments
  • City or Township Governments
  • Special District Governments
  • Indian/Native American Tribal Governments (Federally Recognized)
  • Indian/Native American Tribal Governments (Other than Federally Recognized).

Federal Governments

  • Eligible Agencies of the Federal Government
  • U.S. Territory or Possession

Other

  • Independent School Districts
  • Public Housing Authorities/Indian Housing Authorities
  • Native American Tribal Organizations (other than Federally recognized tribal governments)
  • Faith-based or Community-based Organizations
  • Regional Organizations

Foreign Organizations/International Collaborations

Non-domestic (non-U.S.) Entities (Foreign Organizations) are not eligible to apply.

Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply.

Foreign components, as defined in the NIH Grants Policy Statement, are not allowed.

NIH will no longer issue awards (i.e., new, renewal, or non-competing continuation) to domestic or foreign entities that involve foreign subawards/subcontracts. All NIH-funded research involving foreign subawards/subcontracts must be submitted in response to a NOFO that is specifically designated for funded international collaborations. See NIH Grants Policy Statement 16.8 Collaborative International Research Awards.

Applications involving foreign subawards/subcontracts submitted in response to this NOFO will be deemed noncompliant and will not be considered for funding. This policy applies to all monetary international collaborations resulting in foreign subawards/subcontracts, however, it does not preclude unfunded international collaborations or foreign components, funding for foreign consultants, or procurement of unique equipment or supplies from foreign vendors.

Required Registrations

Applicant Organizations

Applicant organizations must complete and maintain the following registrations as described in the How to Apply- Application Guide to be eligible to apply for or receive an award. All registrations must be completed prior to the application being submitted. Registration can take 6 weeks or more, so applicants should begin the registration process as soon as possible. Failure to complete registrations in advance of a due date is not a valid reason for a late submission, please reference the NIH Grants Policy Statement Section 2.3.9.2 Electronically Submitted Applications for additional information.

  • System for Award Management (SAM) – Applicants must complete and maintain an active registration, which requires renewal at least annually. The renewal process may require as much time as the initial registration. SAM registration includes the assignment of a Commercial and Government Entity (CAGE) Code for domestic organizations which have not already been assigned a CAGE Code. Foreign organizations must obtain a NATO Commercial and Government Entity (NCAGE) Code (in lieu of a CAGE code) in order to register in SAM.
    • Unique Entity Identifier (UEI)- A UEI is issued as part of the SAM.gov registration process. The same UEI must be used for all registrations, as well as on the grant application.
  • eRA Commons - Once the unique organization identifier is established, organizations can register with eRA Commons in tandem with completing their Grants.gov registrations; all registrations must be in place by time of submission. eRA Commons requires organizations to identify at least one Signing Official (SO) and at least one Program Director/Principal Investigator (PD/PI) account in order to submit an application.
  • Grants.gov – Applicants must have an active SAM registration in order to complete the Grants.gov registration.

Program Directors/Principal Investigators (PD(s)/PI(s))

All PD(s)/PI(s) must have an eRA Commons account.  PD(s)/PI(s) should work with their organizational officials to either create a new account or to affiliate their existing account with the applicant organization in eRA Commons. If the PD/PI is also the organizational Signing Official, they must have two distinct eRA Commons accounts, one for each role. Obtaining an eRA Commons account can take up to 2 weeks.

All PD(s)/PI(s) must be registered with ORCID. The personal profile associated with the PD(s)/PI(s) eRA Commons account must be linked to a valid ORCID ID. For more information on linking an ORCID ID to an eRA Commons personal profile see the ORCID topic in our eRA Commons online help.

Eligible Individuals (Program Director/Principal Investigator)

Any individual(s) with the skills, knowledge, and resources necessary to carry out the proposed research as the Program Director(s)/Principal Investigator(s) (PD(s)/PI(s)) is invited to work with their organization to develop an application for support.

For institutions/organizations proposing multiple PDs/PIs, visit the Multiple Program Director/Principal Investigator Policy and submission details in the Senior/Key Person Profile (Expanded) Component of the How to Apply-Application Guide.

2. Cost Sharing

This NOFO does not require cost sharing as defined in the NIH Grants Policy Statement Section 1.2 Definition of Terms.

3. Additional Information on Eligibility

Number of Applications

Applicant organizations may submit more than one application, provided that each application is scientifically distinct.

The NIH will not accept duplicate or highly overlapping applications under review at the same time, per NIH Grants Policy Statement Section 2.3.7.4 Submission of Resubmission Application. This means that the NIH will not accept:

  • A new (A0) application that is submitted before issuance of the summary statement from the review of an overlapping new (A0) or resubmission (A1) application.
  • A resubmission (A1) application that is submitted before issuance of the summary statement from the review of the previous new (A0) application.
  • An application that has substantial overlap with another application pending appeal of initial peer review (see NIH Grants Policy Statement 2.3.9.4 Similar, Essentially Identical, or Identical Applications).

Section IV. Application and Submission Information

1. Requesting an Application Package

The application forms package specific to this opportunity must be accessed through ASSIST, Grants.gov Workspace or an institutional system-to-system solution. Links to apply using ASSIST or Grants.gov Workspace are available in Part 1 of this NOFO. See your administrative office for instructions if you plan to use an institutional system-to-system solution.

2. Content and Form of Application Submission

It is critical that applicants follow the instructions in the Research (R) Instructions in the How to Apply - Application Guide except where instructed in this notice of funding opportunity to do otherwise (in this NOFO, in a policy notice, or other notice from NIH Guide for Grants and Contracts). Conformance to the requirements in the Application Guide is required and strictly enforced. Applications that are out of compliance with these instructions may be delayed or not accepted for review.

Page Limitations

All page limitations described in the How to Apply- Application Guide and the Table of Page Limits must be followed.

Instructions for Application Submission

The following section supplements the instructions found in the How to Apply- Application Guide and should be used for preparing an application to this NOFO.

SF424(R&R) Cover

All instructions in the How to Apply - Application Guide must be followed.

SF424(R&R) Project/Performance Site Locations

All instructions in the How to Apply- Application Guide must be followed.

SF424(R&R) Other Project Information

All instructions in the How to Apply- Application Guide must be followed.

SF424(R&R) Senior/Key Person Profile

All instructions in the How to Apply- Application Guide must be followed.

R&R or Modular Budget

All instructions in the How to Apply- Application Guide must be followed.

Costs should include, but are not limited to, costs for the following:

  • Day-to-day operations.
  • Training and certification of staff in needed operations and procedures (e.g., data entry and transmission systems, etc.).
  • Planning and conducting periodic consortium-wide meetings and conference calls for the ADAPT SC, CEACR, and external expert committee (the members will be appointed by NIDCR and should not be named in the application), including costs for meeting space; preparing minutes of meetings and distributing to members. The budget should include funds supporting the travel costs of selected CEED personnel to annual in-person meetings during the first three years in the Bethesda, Maryland area.
  • Compensating consultants to serve as members of the external expert committee.
  • Hosting webinars and teleconferences.
  • Cost for conducting community engagement evaluation study, including the cloud costs (for data storage and data analytics) for the SCHARE workspace and data sharing.
  • Consultation to the CBPR project PIs/PDs and designated staff on the collection of common data elements, data management and analytics in SCHARE workspace.

R&R Subaward Budget

All instructions in the How to Apply - Application Guide must be followed.

PHS 398 Cover Page Supplement

All instructions in the How to Apply - Application Guide must be followed.

PHS 398 Research Plan

All instructions in the How to Apply - Application Guide must be followed, with the following additional instructions:

Research Strategy:

The Research Strategy must include a description of the proposed CEED structure, as well as activities, strategies, timeline, platforms and available resources for accomplishing the three domains of coordination hub responsibilities. Applications should include a plan that demonstrates infrastructure and personnel readily available to accomplish CEED activities and processes, including relevant support services, data harmonization, management and analytic support, and real-time analytic capacity. In addition, the following information should be provided if not included in above descriptions:

  • Without duplicating information in the biosketches, describe the applicant’s team and level of experience in coordinating a complex research consortium, including degree of scientific emphasis on community-based interventions and populations that experience chronic disease risks and burdens.
  • Describe an overall strategy for addressing the aims of CEED. Describe how the proposed coordination hub will interact with funded CBPR projects to accomplish these goals. Provide a governance approach, logic model, timelines, plans for conflict resolution, and an organizational chart as appropriate.
  • Describe the existing expertise in data science, large population-based database relevant to clinical, public health, economic, and social science, Terra, and computing coding language including Python and R.
  • Propose an approach for community engagement evaluation using relevant theoretical frameworks/models to continuously monitor and improve community-researcher partnerships, and describe the expertise in relevant planning, evaluation, and quality improvement in the context of research and/or public health projects.
  • Describe the existing infrastructure at the applicant’s institution(s), current capacity, research activities, data platforms, and how it will support the consortium.
  • For each of the three required CEED domains, describe specific activities and strategies that will meet the goals of the consortium and how the various activities will interact/intersect.
  • Describe plans for monitoring progress of the consortium activities and operations. Briefly describe how CEED will flexibly adapt to or eliminate processes based on the needs of CBPR teams, guidance provided by NIDCR science officers and/or CEACR, and will manage the continuing needs in the consortium.

Resource Sharing Plan: Individuals are required to comply with the instructions for the Resource Sharing Plans as provided in the How to Apply - Application Guide.

 Other Plan(s): 

All instructions in the How to Apply - Application Guide must be followed, with the following additional instructions:

  • A Data Management and Sharing Plan (DMS Plan) is required for any NIH-funded or conducted research that will generate scientific data. Applicants must submit the DMS Plan at the time of application using the NIH DMS Plan Format Page. The DMS Plan must address the elements in the structured format should not exceed two (2) pages. Where the DMS Plan Format Page requires a “Yes or No” response, no additional narrative is allowed. 
  • All applications responding to this NOFO are encouraged to leverage the NIH SCHARE platform for data storage during the project period (cloud costs must be budgeted) and also for data repository (no cost/budget is required) after the completion of the project

Appendix: Only limited Appendix materials are allowed. Follow all instructions for the Appendix as described in the How to Apply - Application Guide.

  • No publications or other material, with the exception of blank questionnaires or blank surveys, may be included in the Appendix.

PHS Human Subjects and Clinical Trials Information

When involving human subjects research, clinical research, and/or NIH-defined clinical trials (and when applicable, clinical trials research experience) follow all instructions for the PHS Human Subjects and Clinical Trials Information form in the How to Apply- Application Guide, with the following additional instructions:

If you answered “Yes” to the question “Are Human Subjects Involved?” on the R&R Other Project Information form, you must include at least one human subjects study record using the Study Record: PHS Human Subjects and Clinical Trials Information form or Delayed Onset Study record.

Study Record: PHS Human Subjects and Clinical Trials Information

All instructions in the How to Apply - Application Guide must be followed.

A community engagement evaluation study should be included to describe the human subjects research associated with collecting quantitative and qualitative data from CBPR investigators and community partners.

Delayed Onset Study

Note: Delayed onset does NOT apply to a study that can be described but will not start immediately (i.e., delayed start). All instructions in the How to Apply- Application Guide must be followed.

PHS Assignment Request Form

All instructions in the How to Apply- Application Guide must be followed.

3. Unique Entity Identifier and System for Award Management (SAM)

See Part 2. Section III.1 for information regarding the requirement for obtaining a unique entity identifier and for completing and maintaining active registrations in System for Award Management (SAM), NATO Commercial and Government Entity (NCAGE) Code (if applicable), eRA Commons, and Grants.gov

4. Submission Dates and Times

Part I. contains information about Key Dates and times. Applicants are encouraged to submit applications before the due date to ensure they have time to make any application corrections that might be necessary for successful submission. When a submission date falls on a weekend or Federal holiday, the application deadline is automatically extended to the next business day.

Organizations must submit applications to Grants.gov (the online portal to find and apply for grants across all Federal agencies). Applicants must then complete the submission process by tracking the status of the application in the eRA Commons, NIH’s electronic system for grants administration. NIH and Grants.gov systems check the application against many of the application instructions upon submission. Errors must be corrected and a changed/corrected application must be submitted to Grants.gov on or before the application due date and time.  If a Changed/Corrected application is submitted after the deadline, the application will be considered late. Applications that miss the due date and time are subjected to the NIH Grants Policy Statement Section 2.3.9.2 Electronically Submitted Applications.

Applicants are responsible for viewing their application before the due date in the eRA Commons to ensure accurate and successful submission.

Information on the submission process and a definition of on-time submission are provided in the How to Apply-Application Guide.

5. Intergovernmental Review (E.O. 12372)

This initiative is not subject to intergovernmental review.

6. Funding Restrictions

All NIH awards are subject to the terms and conditions, cost principles, and other considerations described in the NIH Grants Policy Statement.

Pre-award costs are allowable only as described in the NIH Grants Policy Statement Section 7.9.1 Selected Items of Cost.

7. Other Submission Requirements and Information

Applications must be submitted electronically following the instructions described in the How to Apply – Application Guide. Paper applications will not be accepted.

Applicants must complete all required registrations before the application due date. Section III. Eligibility Information contains information about registration.

For assistance with your electronic application or for more information on the electronic submission process, visit How to Apply – Application Guide. If you encounter a system issue beyond your control that threatens your ability to complete the submission process on-time, you must follow the Dealing with System Issues guidance. For assistance with application submission, contact the Application Submission Contacts in Section VII.

Important reminders:

All PD(s)/PI(s) must include their eRA Commons ID in the Credential field of the Senior/Key Person Profile form. Failure to register in the Commons and to include a valid PD/PI Commons ID in the credential field will prevent the successful submission of an electronic application to NIH. See Section III of this NOFO for information on registration requirements.

The applicant organization must ensure that the unique entity identifier provided on the application is the same identifier used in the organization’s profile in the eRA Commons and for the System for Award Management. Additional information may be found in the How to Apply – Application Guide.

See more tips for avoiding common errors.

Upon receipt, applications will be evaluated for completeness and compliance with application instructions by the Center for Scientific Review and responsiveness by components of participating organizations, NIH. Applications that are incomplete, non-compliant and/or nonresponsive will not be reviewed. 

Mandatory Disclosure

Recipients or subrecipients must submit any information related to violations of federal criminal law involving fraud, bribery, or gratuity violations potentially affecting the federal award. See Mandatory Disclosures, 2 CFR 200.113 and NIH Grants Policy Statement Section 4.1.35.

Send written disclosures to the NIH Chief Grants Management Officer listed on the Notice of Award for the IC that funded the award and to the HHS Office of Inspector Grant Self Disclosure Program at grantdisclosures@oig.hhs.gov.

Post Submission Materials

Applicants are required to follow the instructions for post-submission materials, as described in the policy

Any instructions provided here are in addition to the instructions in the policy.

Section V. Application Review Information

1. Criteria

Only the review criteria described below will be considered in the review process. Applications submitted to the NIH in support of the NIH mission are evaluated for scientific and technical merit through the NIH peer review system.

Overall Impact

Reviewers will provide an overall impact score to reflect their assessment of the likelihood for the project to exert a sustained, powerful influence on the research field(s) involved, in consideration of the following scored review criteria and additional review criteria (as applicable for the project proposed). An application does not need to be strong in all categories to be judged likely to have a major scientific impact.

Scored Review Criteria

Reviewers will consider Factors 1, 2 and 3 in the determination of scientific merit, and in providing an overall impact score. In addition, Factors 1 and 2 will each receive a separate factor score. 

 

Significance

  • Evaluate the importance of the proposed research in the context of current scientific challenges and opportunities, either for advancing knowledge within the field, or more broadly. Assess whether the application addresses an important gap in knowledge in the field, would solve a critical problem, or create a valuable conceptual or technical advance.
  • Evaluate the rationale for undertaking the study, the rigor of the scientific background for the work (e.g., prior literature and/or preliminary data) and whether the scientific background justifies the proposed study.

Innovation

  • Evaluate the extent to which innovation influences the importance of undertaking the proposed research. Note that while technical or conceptual innovation can influence the importance of the proposed research, a project that is not applying novel concepts or approaches may be of critical importance for the field.
  • Evaluate whether the proposed work applies novel concepts, methods or technologies or uses existing concepts, methods, technologies in novel ways, to enhance the overall impact of the project.

Specific to this NOFO:

  • Evaluate the likelihood that completion of the proposed CEED activities will enhance collaboration, community engagement, and methodological rigor and reproducibility of the CBPR projects in the consortium.
  • Assess whether the organizational concepts or management strategies in coordinating the CBPR Consortium are novel yet sufficiently flexible to accommodate different types of research projects and community partnerships. 

 

Approach

  • Evaluate the scientific quality of the proposed work. Evaluate the likelihood that compelling, reproducible findings will result (rigor) and assess whether the proposed studies can be done well and within the timeframes proposed (feasibility).

Rigor:

  • Evaluate the potential to produce unbiased, reproducible, robust data.
  • Evaluate the rigor of experimental design and whether appropriate controls are in place.
  • Evaluate whether the sample size is sufficient and well-justified.
  • Assess the quality of the plans for analysis, interpretation, and reporting of results.
  • Evaluate whether the investigators presented adequate plans to address relevant biological variables, such as sex or age, in the design, analysis, and reporting.
  • For applications involving human subjects or vertebrate animals, also evaluate:
    • the rigor of the intervention or study manipulation (if applicable to the study design).
    • whether outcome variables are justified.
    • whether the results will be generalizable or, in the case of a rare disease/special group, relevant to the particular subgroup.
    • whether the study population appropriately models the target population.
  • For applications involving human subjects, including clinical trials, assess the adequacy of inclusion plans as appropriate for the scientific goals of the research. Considerations of appropriateness may include disease/condition/behavior incidence, prevalence, or population burden, population representation, and/or current state of the science.

Feasibility:

  • Evaluate whether the proposed approach is sound and achievable, including plans to address problems or new challenges that emerge in the work. For proposed studies in which feasibility may be less certain, evaluate whether the uncertainty is balanced by the potential for major advances.
  • For applications involving human subjects, including clinical trials, evaluate the adequacy and feasibility of the plan to recruit and retain a study population that appropriately models the target population. Additionally, evaluate the likelihood of successfully achieving the proposed enrollment based on age, race, ethnicity, and sex.
  • For clinical trial applications, evaluate whether the study timeline and milestones are feasible.

Specific to this NOFO:

  • Evaluate the quality and appropriateness of proposed plans to provide consultation and technical assistance to CBPR projects regarding methodology and statistical approaches to examining community- and/or societal-level interventions.
  • Evaluate whether the approaches to evaluate community-researcher partnerships in CBPR are theoretically and scientifically sound and feasible.
  • Evaluate the extent to which proposed coordination hub structures and expertise are clearly defined and adequate to ensure coordination of the ADAPT consortium functions and objectives.

 

Investigator(s)

Evaluate whether the investigator(s) have demonstrated background, training, and expertise, as appropriate for their career stage, to conduct the proposed work. For Multiple Principal Investigator (MPI) applications, assess the quality of the leadership plan to facilitate coordination and collaboration.

Environment

Evaluate whether the institutional resources are appropriate to ensure the successful execution of the proposed work.

Specific to this NOFO:

  • Evaluate the extent to which the research team has relevant experience and expertise across the three primary coordination hub activities: 1) Data Planning, Consultation, and Technical Assistance on Research Methodological and Analytics; 2) Community Engagement Evaluation; 3) ADAPT Consortium Infrastructure and Operational Support.
  • Evaluate the appropriateness of the institutional support, equipment and other physical resources available to the investigators for the success of proposed coordination hub activities and ADAPT consortium it serves. 

Additional Review Criteria

As applicable for the project proposed, reviewers will consider the following additional items while determining scientific and technical merit, but will not give criterion scores for these items, and should consider them in providing an overall impact score.

 

For research that involves human subjects but does not involve one of the categories of research that are exempt under 45 CFR Part 46, evaluate the justification for involvement of human subjects and the proposed protections from research risk relating to their participation according to the following five review criteria: 1) risk to subjects; 2) adequacy of protection against risks; 3) potential benefits to the subjects and others; 4) importance of the knowledge to be gained; and 5) data and safety monitoring for clinical trials.

For research that involves human subjects and meets the criteria for one or more of the categories of research that are exempt under 45 CFR Part 46, evaluate: 1) the justification for the exemption; 2) human subjects involvement and characteristics; and 3) sources of materials. For additional information on review of the Human Subjects section, please refer to the Guidelines for the Review of Human Subjects.

This NOFO only accepts applications that do not propose clinical trials. Note: Applications may propose activities involving human subjects that are not deemed clinical trials.


 

When the proposed research includes Vertebrate Animals, evaluate the involvement of live vertebrate animals according to the following criteria: (1) description of proposed procedures involving animals, including species, strains, ages, sex, and total number to be used; (2) justifications for the use of animals versus alternative models and for the appropriateness of the species proposed; (3) interventions to minimize discomfort, distress, pain and injury; and (4) justification for euthanasia method if NOT consistent with the AVMA Guidelines for the Euthanasia of Animals. For additional information on review of the Vertebrate Animals section, please refer to the Worksheet for Review of the Vertebrate Animals Section.


 

When the proposed research includes Biohazards, evaluate whether specific materials or procedures that will be used are significantly hazardous to research personnel and/or the environment, and whether adequate protection is proposed.


 

As applicable, evaluate the full application as now presented.


 

As applicable, evaluate the progress made in the last funding period.


 

As applicable, evaluate the appropriateness of the proposed expansion of the scope of the project.


Additional Review Considerations

As applicable for the project proposed, reviewers will consider each of the following items, but will not give scores for these items, and should not consider them in providing an overall impact score.

 

For projects involving key biological and/or chemical resources, evaluate the brief plans proposed for identifying and ensuring the validity of those resources.


 

Evaluate whether the budget and the requested period of support are fully justified and reasonable in relation to the proposed research.


2. Review and Selection Process

Applications will be evaluated for scientific and technical merit by an appropriate Scientific Review Group convened by the Center for Scientific Review, in accordance with NIH peer review policies and practices, using the stated review criteria. Assignment to a Scientific Review Group will be shown in the eRA Commons.

As part of the scientific peer review, all applications will receive a written critique.

Applications may undergo a selection process in which only those applications deemed to have the highest scientific and technical merit (generally the top half of applications under review) will be discussed and assigned an overall impact score.

Requests for reconsideration of initial peer review will not be accepted for applications submitted in response to this NOFO. 

Applications will be assigned on the basis of established PHS referral guidelines to the appropriate NIH Institute or Center. Applications will compete for available funds with all other recommended applications submitted in response to this NOFO. Following initial peer review, recommended applications will receive a second level of review by the National Advisory Dental and Craniofacial Research Council. The following will be considered in making funding decisions:

  • Scientific and technical merit of the proposed project as determined by scientific peer review.
  • Availability of funds.
  • Relevance of the proposed project to program priorities.

If the application is under consideration for funding, NIH will request "just-in-time" information from the applicant as described in the NIH Grants Policy Statement Section 2.5.1. Just-in-Time Procedures. This request is not a Notice of Award nor should it be construed to be an indicator of possible funding.

Prior to making an award, NIH reviews an applicant’s federal award history in SAM.gov to ensure sound business practices. An applicant can review and comment on any information in the Responsibility/Qualification records available in SAM.gov. NIH will consider any comments by the applicant in the Responsibility/Qualification records in SAM.gov to ascertain the applicant’s integrity, business ethics, and performance record of managing Federal awards per 2 CFR Part 200.206 “Federal awarding agency review of risk posed by applicants.” This provision will apply to all NIH grants and cooperative agreements except fellowships.

3. Anticipated Announcement and Award Dates

After the peer review of the application is completed, the PD/PI will be able to access his or her Summary Statement (written critique) via the eRA Commons. Refer to Part 1 for dates for peer review, advisory council review, and earliest start date.

Information regarding the disposition of applications is available in the NIH Grants Policy Statement Section 2.4.4 Disposition of Applications.

Section VI. Award Administration Information

1. Award Notices

A Notice of Award (NoA) is the official authorizing document notifying the applicant that an award has been made and that funds may be requested from the designated HHS payment system or office. The NoA is signed by the Grants Management Officer and emailed to the recipient’s business official.

In accepting the award, the recipient agrees that any activities under the award are subject to all provisions currently in effect or implemented during the period of the award, other Department regulations and policies in effect at the time of the award, and applicable statutory provisions.

Recipients must comply with any funding restrictions described in Section IV.6. Funding Restrictions. Any pre-award costs incurred before receipt of the NoA are at the applicant's own risk.  For more information on the Notice of Award, please refer to the NIH Grants Policy Statement Section 5. The Notice of Award and NIH Grants & Funding website, see Award Process.

Institutional Review Board or Independent Ethics Committee Approval: Recipient institutions must ensure that protocols are reviewed by their IRB or IEC. To help ensure the safety of participants enrolled in NIH-funded studies, the recipient must provide NIH copies of documents related to all major changes in the status of ongoing protocols.

2. Administrative and National Policy Requirements

The following Federal wide and HHS-specific policy requirements apply to awards funded through NIH:

All federal statutes and regulations relevant to federal financial assistance, including those highlighted in NIH Grants Policy Statement Section 4 Public Policy Requirements, Objectives and Other Appropriation Mandates.

By applying for or accepting federal funds from HHS, recipients certify compliance with all federal antidiscrimination laws and these requirements and that complying with those laws is a material condition of receiving federal funding streams. Recipients are responsible for ensuring subrecipients, contractors, and partners also comply.

Applicants and recipients are strongly encouraged to refer to the NIH Director’s Statement of Priorities, entitled “Advancing NIH’s Mission Through a Unified Strategy.” 

Recipients are responsible for ensuring that their activities comply with all applicable federal regulations. Pursuant to 2 CFR 200.340, by accepting an NIH award, the recipient agrees that continued funding for the award is contingent upon the availability of appropriated funds, recipient satisfactory performance, compliance with the Terms and Conditions of the award, and may also otherwise be terminated, to the extent authorized by law, if the agency determines that the award no longer effectuates the program goals or agency priorities, in line with 2 CFR 200.340(a)(4).

Pursuant to the Cybersecurity Act of 2015, Div. N, § 405, Pub. Law 114-113, 6 USC § 1533(d), the HHS Secretary has established a common set of voluntary, consensus-based, and industry-led guidelines, best practices, methodologies, procedures, and processes.

Successful recipients under this NOFO agree that:

When recipients, subrecipients, or third-party entities have:

  • ongoing and consistent access to HHS owned or operated information or operational technology systems; and
  • receive, maintain, transmit, store, access, exchange, process, or utilize personal identifiable information (PII) or personal health information (PHI) obtained from the awarding HHS agency for the purposes of executing the award.

Cybersecurity plans and procedures must at minimum include the following:

  • Develop cybersecurity plans and procedures, modeled after the NIST Cybersecurity framework, to protect HHS systems and data:
    • Identify:
      • Develop an inventory of all assets and accounts with access to HHS owned and operated information or operational technology systems or which obtain PII or PHI for the purposes of the award.
    • Protect:
      • Limit access to HHS owned and operated systems to only those in need of access to complete reward activities.
      • Require all staff to complete annual cybersecurity and privacy awareness training. Visit 405(d): Knowledge on Demand (hhs.gov) to obtain free trainings, if needed.
      • Enable multifactor authentication for all employees, subrecipients, and third-party entities to access HHS owned and operated information or operational technology systems.
      • Regularly backup sensitive data and test backups.
    • Detect:
      • Install anti-virus or anti-malware software on all devices, servers, and accounts used to connect to HHS owned and operated systems.
    • Respond:
      • Develop an incident response plan. See Incident-Response-Plan-Basics_508c.pdf (cisa.gov) to learn about developing incident response plans.
      • Have cybersecurity incident reporting procedures that ensure the relevant HHS awarding agencies are notified of a cybersecurity incident within 48 hours of discovery. A cybersecurity incident is defined as an unplanned interruption to a technology service or reduction in the quality of a technology service, or an occurrence that actually or potentially jeopardizes the confidentiality, integrity, or availability of an information system or the information the system processes, stores, or transmits.
    • Recover:
      • Investigate incidents and plug any security gaps identified. 

All activities proposed in your application and budget narrative must align with applicable law, including but not limited to statutes, executive orders, federal regulations and applicable judicial holdings.  Accordingly, discretionary awards shall not be used to fund, promote, encourage, subsidize, or facilitate; racial preferences or other forms of racial discrimination by the recipient, including activities where race or intentional proxies for race will be used as a selection criterion for employment or program participation; denial by the recipient of the sex binary in humans, or the belief that sex is a chosen or mutable characteristic; illegal immigration; or any other initiatives that compromise public safety.  If an application does not align, the application will not receive funding to the extent permitted by law and applicable court orders.

Cooperative Agreement Terms and Conditions of Award

The following special terms of award are in addition to, and not in lieu of, otherwise applicable U.S. Office of Management and Budget (OMB) administrative guidelines, U.S. Department of Health and Human Services (HHS) grant administration regulations at 2 CFR Part 200, and other HHS, PHS, and NIH grant administration policies.

The administrative and funding instrument used for this program will be the cooperative agreement, an "assistance" mechanism (rather than an "acquisition" mechanism), in which substantial NIH programmatic involvement with the recipients is anticipated during the performance of the activities. Under the cooperative agreement, the NIH purpose is to support and stimulate the recipients' activities by involvement in and otherwise working jointly with the recipients in a partnership role; it is not to assume direction, prime responsibility, or a dominant role in the activities. Consistent with this concept, the dominant role and prime responsibility resides with the recipients for the project as a whole, although specific tasks and activities may be shared among the recipients and NIH as defined below.

The PD(s)/PI(s) will have the primary responsibility for:

  • Coordination, cooperation, and management of the project with NIDCR, including establishment of the ADAPT Steering Committee (SC) and any working groups in the consortium.
  • Participating in planning of cooperative activities, including inaugural (in person) and annual (virtual, thereafter) consortium meetings, the SC meetings and attendance. Recipient agrees to abide by the procedures and policies established by the SC.
  • Providing administrative and logistical support for the consortium operations, including tracking, scheduling, facilitating meetings and conference calls, and preparing concise minutes or summaries of meetings for distribution.
  • Facilitating consortium-wide use of common data elements across CBPR projects and coordinate implementation and guidance for data collection strategies.
  • Supporting the conduct of data analysis and collaboration in the cloud workspace offering expert assistance and guidance, as needed, to ensure scientific integrity and quality for methods related to data merge, metrics, and application of statistical approaches.
  • Providing expertise and leadership in addressing issues of broad scientific applicability, such as data and intellectual property sharing standards, advanced analytics and methodological approaches, and dissemination of findings
  • Ensure that community engagement evaluation study is carried out in compliance with federal regulatory requirements, including but not limited to those relating to human subject protection, informed consent, and reporting of adverse events.
  • Coordinate consortium-generated publications, code, and to the extent possible, the underlying primary data immediately and broadly available to the public. See Section 8.2.3.1 of the NIH GPS.
  • Recipients will retain custody of and have primary rights to the data and software developed under these awards, subject to Government rights of access consistent with current HHS, PHS, and NIH policies.

NIH staff have substantial programmatic involvement that is above and beyond the normal stewardship role in awards, as described below:

  • NIDCR staff who will serve as Program Official and Project Scientist will be responsible for the normal and/or above and beyond the normal scientific and programmatic stewardship of the award will be named in the award notice.
  • NIDCR staff will maintain consistent communication with CEED PI(s)/PD(s) as well as the consortium members in support of the coordination hub activities.
  • NIDCR staff will periodically review and monitor the progress of CEED activities in relation to their stated objectives and NIH guidelines to ensure the scientific, regulatory, fiscal, and administrative compliances.
  • NIDCR staff will have the option to withhold or reduce support to a participating institution if technical performance requirements are not met or noncompliance to the Terms and Conditions.
  • NIDCR staff will serve as a resource for specific information on NIH's programmatic intentions and priorities, and help to foster collaborations between researchers, public health, and public policy partners both within and across other Federal agencies to increase the value of research to these participants.
  • NIDCR may convene an external expert group and will establish the Memorandum Of Understanding and co-funding with NHLBI to support the scope of CEACR consultative services (longitudinal) for the CBPR Consortium.
  • NIDCR staff will participate in consortium meetings, project conference calls, work group/committee activities, as appropriate, and the SC as non-voting member.
  • NIDCR staff will review data generated under this Cooperative Agreement and in the consortium and monitor progress of the study through periodic reports, site visits, and logs, as appropriate, and provide scientific/programmatic support and guidance.

Areas of Joint Responsibility include:

  • Recipient and NIDCR will jointly develop appropriate confidentiality procedures for data collection, processing, storage and analysis to ensure the confidentiality of data and compliance with local cultures and norms regarding research data handling and governance.
  • Recipient, with assistance from NIH, will ensure the timely and broad dissemination of lessons learned, to inform researchers and relevant service systems as appropriate.
  • The ADAPT SC is the primary governing body of the network and is chaired by personnel from CEED. The SC, with support of CEED, reviews and approves the agenda and priorities for collaborative consortium activities, develops and monitors policies and procedures guiding the consortium activities, and coordinates communications. 
  • The PD(s)/PI(s) provide, with assistance from the NIDCR staff, necessary support to ensure that sites and investigators, and other research partners fully comply with federal regulatory requirements, including but not limited to those relating to human subject protection, informed consent, and reporting of adverse events.

Dispute Resolution:

Any disagreements that may arise in scientific or programmatic matters (within the scope of the award) between recipients and NIH may be brought to Dispute Resolution. A Dispute Resolution Panel composed of three members will be convened: a designee of the Steering Committee chosen without NIH staff voting, one NIH designee, and a third designee with expertise in the relevant area who is chosen by the other two; in the case of individual disagreement, the first member may be chosen by the individual recipient. This special dispute resolution procedure does not alter the recipient's right to appeal an adverse action that is otherwise appealable in accordance with PHS regulation 42 CFR Part 50, Subpart D and HHS regulation 45 CFR Part 16.

3. Data Management and Sharing

A Data Management and Sharing Plan (DMS Plan) is required for any NIH-funded or conducted research that will generate scientific data. Applicants must submit the DMS Plan at the time of application using the NIH DMS Plan Format Page. The DMS Plan must address the elements in the structured format should not exceed two (2) pages. Where the DMS Plan Format Page requires a “Yes or No” response, no additional narrative is allowed. 

  • All prospective applications responding to this NOFO, regardless of the amount of direct costs requested for any one year, must submit a DMS Plan leveraging the NIH SCHARE platform. Specifically, each applicant should estimate cloud costs (for data storage and data analytics) for the proposed project and include the budget.
  • The applicants are also encouraged to use SCHARE data repository after the completion of the project (no cost/budget is required).

4. Reporting

When multiple years are involved, recipients will be required to submit the Research Performance Progress Report (RPPR) annually and financial statements as required in the NIH Grants Policy Statement Section 8.4.1 Reporting. To learn more about post-award monitoring and reporting, see the NIH Grants & Funding website, see Post-Award Monitoring and Reporting.

A final RPPR, invention statement, and the expenditure data portion of the Federal Financial Report are required for closeout of an award, as described in the NIH Grants Policy Statement Section 8.6 Closeout. NIH NOFOs outline intended research goals and objectives. Post award, NIH will review and measure performance based on the details and outcomes that are shared within the RPPR, as described at 2 CFR Part 200.301.

5. Evaluation

Section VII. Agency Contacts

We encourage inquiries concerning this funding opportunity and welcome the opportunity to answer questions from potential applicants.

Application Submission Contacts

eRA Service Desk - Questions regarding ASSIST, eRA Commons, application errors and warnings, documenting system problems that threaten submission by the due date, and post-submission issues.

Grants.gov Support Center - Questions regarding Grants.gov registration and services (e.g., Workspace, subscriptions).

Scientific/Research Contact(s)

National Institute of Dental and Craniofacial Research (NIDCR)
Email: NIDCR-ADAPT@nih.gov

Office of Research on Women's Health (ORWH) 
Email: idr-orwh@mail.nih.gov

Office of Disease Prevention (ODP) 
Email: ODP-NOFO@mail.nih.gov

Office of AIDS Research (OAR)
Email: OARinfo@nih.gov

Peer Review Contact(s)

Center for Scientific Review (CSR)
Email: NOFOReviewContact@csr.nih.gov

Financial/Grants Management Contact(s)

National Institute of Dental and Craniofacial Research (NIDCR)
Email: deeranotifications@nidcr.nih.gov

Section VIII. Other Information

Recently issued trans-NIH policy notices may affect your application submission. A full list of policy notices published by NIH is provided in the NIH Guide for Grants and Contracts. All awards are subject to the terms and conditions, cost principles, and other considerations described in the NIH Grants Policy Statement.

Authority and Regulations

Awards are made under the authorization of Sections 301 and 405 of the Public Health Service Act as amended (42 USC 241 and 284) and under Federal Regulations 42 CFR Part 52 and 2 CFR Part 200.